The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical trials to confirm these findings.
Diabetes medications may help lower COPD flare-up risk, study finds
- Post author:admin
- Post published:February 11, 2025
- Post category:uncategorized